EPIVAC
Effectiveness of pneumococcal and influenza vaccines
The EPIVAC group was formed within the primary health services of Tarragona-Valls and comprises a multidisciplinary group of researchers and primary health care professionals. It is a well consolidated group accredited by IDIAP Jordi Gol and by AGAUR (agency for the management of university and research grants of the Catalan Generalitat). Basically the group carries out population-based clinical an epidemiological research into infectious respiratory diseases which are preventable by vaccination.
The group participates in the following projects
PI: Aragón Pérez, María. vACCine covid-19 monitoring readinESS (ACCESS). Funding: UMC Utrecht (University Medical Center Utrecht). Duration: 2020 - 2022 |
PI: Vila Corcoles, Angel. Incidencia y caracterización de perfiles de bajo/alto riesgo de complicación en personas >60 años con COVID19. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2021 |
PI: Gens Barberà, Montserrat. Efectividad de la implementación de distintas herramientas de Seguridad del Paciente para definir un nuevo mapa de riesgo en Atención Primaria. Funding: Instituto de Salud Carlos III. Duration: 2018 - 2021 |
PI: Moral Parras, Pedro. Portadores intestinales comunitarios de Enterobacterias productoras de lactamasas de espectro extendido y carbapenemasas plasmídicas en las Regiones Sanitarias Terres de l'Ebre, Camp de Tarragona y Girona. Funding: Fundacio Doctor Ferran. Duration: 2019 - 2020 |
PI: Hernandez Vidal, Nuria. Mapa de riscos en Atenció Domiciliària. Funding: IDIAP Jordi Gol. Duration: 2019 - 2020 |
PI: Hernandez Vidal, Nuria. Monitoratge de la cultura de seguretat en Atenció Primària mitjançant la validació de la versió catalana del qüestionari MOSPSC (Medical Office Survey on Patient Safety Culture). Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020 |
PI: Vila Corcoles, Angel. Efectividad clínica de la vacuna antineumocócica conjugada 13-valente versus vacuna polisacárida 23-valente en los adultos mayores de 50 años: estudio de cohortes de base poblacional. Funding: Instituto de Salud Carlos III. Duration: 2016 - 2020 |
The group participates in the following publications
Vila A, Ochoa O, Torrente C, Vila A, Satué EM, Hospital I, de Diego C, Gómez FF, Basora J. Evaluación de la incidencia y perfil de riesgo de Covid-19 según comorbilidad previa en adultos ?50 años del área de Tarragona. Rev Esp Salud Publica. 2020;94:1-15. PMID:3258837. IF: 0,746. |
Vila-Corcoles A, Hospital I, Ochoa-Gondar O, Satue E, de Diego C, Vila-Rovira A, Gómez-Bertomeu F, Raga X, Aragón M. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016. Vaccine. 2020 Jan; 38(5):1170-1180. doi:10.1016/j.vaccine.2019.11.012. Epub 2019 Nov 20. PMID:31759735. IF: 3,143. |
Vila-Córcoles A, Ochoa-Gondar O, Satué-Gracia EM, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Basora-Gallisà J. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain. BMJ Open. 2020 12; 10(12):e041577. doi:10.1136/bmjopen-2020-041577. Epub 2020 Dec 10. pmc:PMC7733229. PMID:33303459. IF: 2,496. |
Vila-Córcoles Á, Ochoa-Gondar O, Torrente-Fraga C, Vila-Rovira Á, Satué-Gracia E, Hospital-Guardiola I, de Diego-Cabanes C, Gómez-Bertomeu F, Basora-Gallisà J. [Evaluation of incidence and risk profile for suffering Covid-19 infection by underlying conditions among middle-aged and older adults in Tarragona.]. Rev Esp Salud Publica. 2020 Jun; 94. Epub 2020 Jun 26. Spanish. PMID:32588837. IF: 0,746. |
Vila-Corcoles A, Ochoa-Gondar O, Vila-Rovira A, Aragon M, Esteban-Julvez L, Chamorro N, Hospital I, Satue E, Blade J, de Diego C, Gomez-Bertomeu F, Raga X. Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study. Lung. 2020 06; 198(3):481-489. doi:10.1007/s00408-020-00349-y. Epub 2020 Apr 06. PMID:32253492. IF: 1,817. |
Vila-Corcoles A, Satue-Gracia E, Ochoa-Gondar O, Torrente-Fraga C, Gomez-Bertomeu F, Vila-Rovira A, Hospital-Guardiola I, de Diego-Cabanes C, Bejarano-Romero F, Rovira-Veciana D, Basora-Gallisa J. Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain. J Clin Hypertens (Greenwich). 2020 08; 22(8):1379-1388. doi:10.1111/jch.13948. Epub 2020 Jul 25. PMID:32710674. IF: 2,719. |
Indicators
Indicator |
2020 |
---|---|
Researchers with PhD |
19 |
Total number of projects in which group members have participated |
7 |
Total number of projects in which the PI of the project has belonged to the group |
2 |
Total Funding |
143.581 € |
Scientific publications in indexed journals |
6 |
Total Impact factor |
11,67 |
Nº of articles in Q1 journals |
0 |
Q1 IF |
|
Nº of articles in Q2 journals |
3 |
Q2 IF |
8,358 |